Copy number variations of complement component c4 are associated with Behçet's disease but not with ankylosing spondylitis associated with acute anterior uveitis

Arthritis and Rheumatism

Volumn 65, Issue 11, 2013, Pages 2963-2970

  Hou, Shengping ^a   Qi, Jian ^a   Liao, Dan ^a   Zhang, Qi ^a   Fang, Jing ^a   Zhou, Yan ^a   Liu, Yunjia ^a   Bai, Lin ^a   Zhang, Meifen ^b   Kijlstra, Aize ^c   Yang, Peizeng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C4; INTERLEUKIN 6;

ANKYLOSING SPONDYLITIS; ARTICLE; BEHCET DISEASE; CD4+ T LYMPHOCYTE; CHINA; CONTROLLED STUDY; COPY NUMBER VARIATION; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IRIDOCYCLITIS; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ACUTE DISEASE; ADULT; BEHCET SYNDROME; COMPLEMENT C4A; COMPLEMENT C4B; FEMALE; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; HLA-B51 ANTIGEN; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; RISK FACTORS; SPONDYLITIS, ANKYLOSING; UVEITIS, ANTERIOR;

EID: 84886782355     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.38116     Document Type: Article

References (50)

1. Suttorp-Schulten MS, Rothova A,. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol 1996; 80: 844-8.
2. Chang JH, Wakefield D,. Uveitis: a global perspective. Ocul Immunol Inflamm 2002; 10: 263-79.
3. Goto H, Mochizuki M, Yamaki K, Kotake S, Usui M, Ohno S,. Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol 2007; 51: 41-4.
4. Yang P, Zhang Z, Zhou H, Li B, Huang X, Gao Y, et al. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res 2005; 30: 943-8.
5. Yang P, Fang W, Meng Q, Ren Y, Xing L, Kijlstra A,. Clinical features of Chinese patients with Behçet's disease. Ophthalmology 2008; 115: 312-8.e4.
6. Van der Heijde D, Machado P, Braun J, Hermann KG, Baraliakos X, Hsu B, et al. MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis. Ann Rheum Dis 2012; 71: 369-73.
7. Braun J, Sieper J,. Ankylosing spondylitis. Lancet 2007; 369: 1379-90.
8. Jha P, Bora PS, Bora NS,. The role of complement system in ocular diseases including uveitis and macular degeneration. Mol Immunol 2007; 44: 3901-8.
9. Jha P, Sohn JH, Xu Q, Nishihori H, Wang Y, Nishihori S, et al. The complement system plays a critical role in the development of experimental autoimmune anterior uveitis. Invest Ophthalmol Vis Sci 2006; 47: 1030-8.
10. Bora NS, Jha P, Bora PS,. The role of complement in ocular pathology. Semin Immunopathol 2008; 30: 85-95.
11. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs K, et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 2006; 38: 458-62.
12. Kondo N, Bessho H, Honda S, Negi A,. Complement factor H Y402H variant and risk of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology 2011; 118: 339-44.
13. Tuo J, Grob S, Zhang K, Chan CC,. Genetics of immunological and inflammatory components in age-related macular degeneration. Ocul Immunol Inflamm 2012; 20: 27-36.
14. Wakefield D, Buckley R, Golding J, McCluskey P, Abi-Hanna D, Charlesworth J, et al. Association of complement allotype C4B2 with anterior uveitis. Hum Immunol 1988; 21: 233-7.
15. Yang MM, Lai TY, Tam PO, Chiang SW, Ng TK, Liu K, et al. Association of C2 and CFB polymorphisms with anterior uveitis. Invest Ophthalmol Vis Sci 2012; 53: 4969-74.
16. Boteva L, Morris DL, Cortes-Hernandez J, Martin J, Vyse TJ, Fernando MM,. Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations. Am J Hum Genet 2012; 90: 445-56.
17. Lv Y, He S, Zhang Z, Li Y, Hu D, Zhu K, et al. Confirmation of C4 gene copy number variation and the association with systemic lupus erythematosus in Chinese Han population. Rheumatol Int 2012; 32: 3047-53.
18. Yang Y, Chung EK, Wu YL, Savelli SL, Nagaraja HN, Zhou B, et al. Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Human Genet 2007; 80: 1037-54.
19. Rigby WF, Wu YL, Zan M, Zhou B, Rosengren S, Carlson C, et al. Increased frequency of complement C4B deficiency in rheumatoid arthritis. Arthritis Rheum 2012; 64: 1338-44.
20. Liu YH, Wan L, Chang CT, Liao WL, Chen WC, Tsai Y, et al. Association between copy number variation of complement component C4 and Graves' disease. J Biomed Sci 2011; 18: 71.
21. Uko G, Christiansen FT, Dawkins RL, McCann VJ,. Reference ranges for serum C4 concentrations in subjects with and without C4 null alleles. J Clin Pathol 1986; 39: 573-6.
22. Welch TR, Brickman C, Bishof N, Maringhini S, Rutkowski M, Frenzke M, et al. The phenotype of SLE associated with complete deficiency of complement isotype C4A. J Clin Immunol 1998; 18: 48-51.
23. Van Zeben D, Giphart MJ, Christiansen FT, Hoetjer M, Meyer EC, Breedveld FC,. Properdin factor B and complement factor C4 allotypes in rheumatoid arthritis: results of a follow-up study. Hum Immunol 1992; 33: 148-51.
24. Gilliam BE, Wolff AE, Moore TL,. Partial C4 deficiency in juvenile idiopathic arthritis patients. J Clin Rheumatol 2007; 13: 256-60.
25. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease [review]. Lancet 1990; 335: 1078-80.
26. Van der Linden S, Valkenburg HA, Cats A,. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361-8.
27. Yabuki K, Ohno S, Mizuki N, Ando H, Tabbara KF, Goto K, et al. HLA class I and II typing of the patients with Behçet's disease in Saudi Arabia. Tissue Antigens 1999; 54: 273-7.
28. Olerup O, Zetterquist H,. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225-35.
29. Hou S, Xiao X, Li F, Jiang Z, Kijlstra A, Yang P,. Two-stage association study in Chinese Han identifies two independent associations in CCR1/CCR3 locus as candidate for Behçet's disease susceptibility. Hum Genet 2012; 131: 1841-50.
30. Hou S, Yang Z, Du L, Jiang Z, Shu Q, Chen Y, et al. Identification of a susceptibility locus in STAT4 for Behçet's disease in Han Chinese in a genome-wide association study. Arthritis Rheum 2012; 64: 4104-13.
31. Grevink ME, Horst G, Limburg PC, Kallenberg CG, Bijl M,. Levels of complement in sera from inactive SLE patients, although decreased, do not influence in vitro uptake of apoptotic cells. J Autoimmun 2005; 24: 329-36.
32. Bardak Y, Aridogan BC,. The demonstration of serum interleukin 6-8, tumor necrosis factor-α, complement, and immunoglobulin levels in Behçet's disease with ocular involvement. Ocul Immunol Inflamm 2004; 12: 53-8.
33. Gul A,. Behçet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 2005; 4: 81-3.
34. Hou S, Yang P, Du L, Zhou H, Lin X, Liu X, et al. SUMO4 gene polymorphisms in Chinese Han patients with Behçet's disease. Clin Immunol 2008; 129: 170-5.
35. Chen Z, Koralov SB, Kelsoe G,. Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. J Exp Med 2000; 192: 1339-52.
36. Zhou ZY, Chen SL, Shen N, Lu Y,. Cytokines and Behçet's disease. Autoimmun Rev 2012; 11: 699-704.
37. Manderson AP, Botto M, Walport MJ,. The role of complement in the development of systemic lupus erythematosus. Annu Review Immunol 2004; 22: 431-56.
38. Law SK, Dodds AW, Porter RR,. A comparison of the properties of two classes, C4A and C4B, of the human complement component C4. EMBO J 1984; 3: 1819-23.
39. Wetsel RA,. Structure, function and cellular expression of complement anaphylatoxin receptors. Curr Opin Immunol 1995; 7: 48-53.
40. Tokoro Y, Seto T, Abe Y, Takahashi H, Takahashi Y,. Skin lesions in Behçet's disease. Int J Dermatol 1977; 16: 227-44.
41. Yurdakul S, Hamuryudan V, Yazici H,. Behçet syndrome. Curr Opin Rheumatol 2004; 16: 38-42.
42. Hauptmann G, Grosshans E, Heid E,. Lupus erythematosus syndrome and complete deficiency of the fourth component of complement. Boll Ist Sieroter Milan 1974; 53 Suppl: 228.
43. Cook HT, Botto M,. Mechanisms of disease: the complement system and the pathogenesis of systemic lupus erythematosus. Nat Clin Pract Rheumatol 2006; 2: 330-7.
44. Steinberg JB, Kapelanski DP, Olson JD, Weiler JM,. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 106: 1008-16.
45. Berk M, Wadee AA, Kuschke RH, O'Neill-Kerr A,. Acute phase proteins in major depression. J Psychosom Res 1997; 43: 529-34.
46. Tuzun E, Scott BG, Goluszko E, Higgs S, Christadoss P,. Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis. J Immunol 2003; 171: 3847-54.
47. Evereklioglu C, Er H, Turkoz Y, Cekmen M,. Serum levels of TNF-α, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease. Mediators Inflamm 2002; 11: 87-93.
48. Horai R, Caspi RR,. Cytokines in autoimmune uveitis. J Interferon Cytokine Res 2011; 31: 733-44.
49. Hohki S, Ohguro N, Haruta H, Nakai K, Terabe F, Serada S, et al. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses. Exp Eye Research 2010; 91: 162-70.
50. Yoshimura T, Sonoda KH, Ohguro N, Ohsugi Y, Ishibashi T, Cua DJ, et al. Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis. Rheumatology (Oxford) 2009; 48: 347-54.